Many cancers - especially ovarian cancer - are diagnosed in later stages when treatment options are limited and outcomes are worse. New diagnostic technology is beginning to emerge that has the potential to identify cancer signals earlier. When these diagnostics gain FDA approval, it is critical that Congress ensures that our most vulnerable populations are able to gain access.

Congress is currently considering the Medicare Multi-Cancer Early Detection Screening Coverage Act (S.2085/H.R.2407). The legislation has gained massive bipartisan support in both the Senate and the House of Representatives, but it has not yet been scheduled for a vote. 

Congress should take action today to pass S.2085/H.R.2407. Please contact your members of Congress today to urge them to pass this important legislation.